Paper34975855
Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice.
Lin WW and 13 others. Front Immunol, 2021. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice. Papers, record 34975855. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34975855
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| Arthritis, Experimental | Major topic |
| Fibrinogen | Major topic |
| Animals | |
| Antigens, CD | |
| Female | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred DBA | |
| NIH 3T3 Cells | |
| T-Lymphocytes | |
| Lymphocyte Activation Gene 3 Protein |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05929989 | Cystatin D Fibrinogen Like Protein 1 | Background |
Source ClinicalTrials.gov
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28494214 | The role and therapeutic targeting of IL-6 in rheumatoid arthritis. | Expert Rev Clin Immunol | 2017 | https://conductscience.org/library/papers/28494214 | PubMed |
| 2 | 19043418 | Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. | Nat Immunol | 2009 | https://conductscience.org/library/papers/19043418 | PubMed |
| 3 | 26530319 | Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/26530319 | PubMed |
| 4 | 33867830 | The role of Fibrinogen-like proteins in Cancer. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/33867830 | PubMed |
| 5 | 15485628 | Role of LAG-3 in regulatory T cells. | Immunity | 2004 | https://conductscience.org/library/papers/15485628 | PubMed |
| 6 | 31907283 | A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases. | J Immunol | 2020 | https://conductscience.org/library/papers/31907283 | PubMed |
| 7 | 24769443 | LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses. | Cancer Res | 2014 | https://conductscience.org/library/papers/24769443 | PubMed |
| 8 | 12223110 | Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice. | Arthritis Res | 2002 | https://conductscience.org/library/papers/12223110 | PubMed |
| 9 | 29417936 | Rheumatoid arthritis. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29417936 | PubMed |
| 10 | 21515267 | Effector T cells in rheumatoid arthritis: lessons from animal models. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21515267 | PubMed |
| 11 | 32718086 | Interleukin-6 in Rheumatoid Arthritis. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32718086 | PubMed |
| 12 | 33216465 | Animal models of rheumatoid arthritis-associated interstitial lung disease. | Immun Inflamm Dis | 2021 | https://conductscience.org/library/papers/33216465 | PubMed |
| 13 | 8717520 | Role of cytokines in rheumatoid arthritis. | Annu Rev Immunol | 1996 | https://conductscience.org/library/papers/8717520 | PubMed |
| 14 | 21873518 | Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. | J Immunol | 2011 | https://conductscience.org/library/papers/21873518 | PubMed |
| 15 | 9159144 | Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9159144 | PubMed |
| 16 | 24286137 | Role of neutrophils in systemic autoimmune diseases. | Arthritis Res Ther | 2013 | https://conductscience.org/library/papers/24286137 | PubMed |
| 17 | 24768768 | Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway. | Cell Signal | 2014 | https://conductscience.org/library/papers/24768768 | PubMed |
| 18 | 18482208 | Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. | Scand J Immunol | 2008 | https://conductscience.org/library/papers/18482208 | PubMed |
| 19 | 31604537 | Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor. | Semin Immunol | 2019 | https://conductscience.org/library/papers/31604537 | PubMed |
| 20 | 19880967 | Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. | Gut | 2010 | https://conductscience.org/library/papers/19880967 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42855599 | LAG3 checkpoint function and its mechanism of action in therapeutic targeting. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42855599 | PubMed |
| 42741709 | Serum Hepatocyte-Derived Fibrinogen-Related Protein-1: A Novel Biomarker for Severity and Clinical Outcome in Acute Ischemic Stroke. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42741709 | PubMed |
| 42683267 | Lymphocyte activation gene 3 in autoimmune disease: from molecular mechanisms to clinical applications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42683267 | PubMed |
| 41789095 | Unraveling fibrinogen-like protein 1's role in immune regulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789095 | PubMed |
| 41629131 | Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41629131 | PubMed |
| 40592325 | Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity. | Cell | 2025 | https://conductscience.org/library/papers/40592325 | PubMed |
| 40514283 | Exploring new frontiers in LAG-3 biology and therapeutics. | Trends Pharmacol Sci | 2025 | https://conductscience.org/library/papers/40514283 | PubMed |
| 40437626 | Activation of eIF2α-ATF4 by endoplasmic reticulum-mitochondria coupling stress enhances COX2 expression and MSC-based therapeutic efficacy for rheumatoid arthritis. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40437626 | PubMed |
| 39228513 | Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus. | J Transl Autoimmun | 2024 | https://conductscience.org/library/papers/39228513 | PubMed |
| 38973608 | Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells. | JCI Insight | 2024 | https://conductscience.org/library/papers/38973608 | PubMed |
| 38399624 | Psoriasis: What Is New in Markers of Disease Severity? | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38399624 | PubMed |
| 37902887 | FGL1 Promotes Tumor Immune Escape in Stomach Adenocarcinoma via the Notch Signaling Pathway. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/37902887 | PubMed |
| 37575235 | The impact of exosomes derived from distinct sources on rheumatoid arthritis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37575235 | PubMed |
| 37314518 | From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases. | Inflamm Res | 2023 | https://conductscience.org/library/papers/37314518 | PubMed |
| 37153794 | Xue-Jie-San restricts ferroptosis in Crohn's disease via inhibiting FGL1/NF-κB/STAT3 positive feedback loop. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37153794 | PubMed |
| 36694465 | Exosomes derived from fibrinogen-like protein 1-overexpressing bone marrow-derived mesenchymal stem cells ameliorates rheumatoid arthritis. | Bioengineered | 2022 | https://conductscience.org/library/papers/36694465 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34975855
GET https://conductscience.org/api/papers/v1/34975855/references?page=2